OM1
PrivateLast Round
Series D
Jul 16, 2021
Total Funding Raised
$171M
Company Overview
OM1 operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series D round in July 2021.
OM1 is a healthcare technology company that provides an AI-powered platform for measuring, comparing, and predicting treatment outcomes using real-world clinical data.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Subscription SaaS
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OM1 Comparables
Compare OM1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealthVerity | 87% | |
| Verana Health | 87% | |
| TriNetX | 87% |
For institutional investors. Book with your work email.
OM1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 16, 2021 | ||||
| Series C | Dec 18, 2019 | ||||
| Series B | May 22, 2018 | ||||
| Series A | Apr 6, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OM1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series D |
| 7wire Ventures | Series C, Series A, Series D, Series B |
| Scale Venture Partners | Series D, Series C |
| General Catalyst | Series C, Series A, Series D, Series B |
| D1 Capital Partners | Series D |
| Polaris Partners | Series C, Series D, Series B |
| Wanxiang Healthcare Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 8, 2026
Added ZS, a healthcare consulting firm, as a customer.
- Feb 8, 2026
Added Ppd Development, Inc. in Pharmaceuticals/Clinical Research as a customer.
For institutional investors. Book with your work email.
OM1 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OM1's valuation, stock price, and market status.
Is OM1 a public or private company?
OM1 is a private company.
What is the current stock price of OM1?
OM1 is a private company, so its shares have no public market price. Caplight tracks OM1's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OM1 worth (valuation)?
Valuation information for OM1 is not publicly available.
Can I buy OM1 stock?
OM1 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OM1's last funding round?
OM1's most recent funding round was Series D on July 16, 2021.
Who are the main investors in OM1?
Key investors in OM1 include Breyer Capital, Scale Venture Partners, D1 Capital Partners, Polaris Partners.
Will OM1 IPO soon?
No public IPO plans have been announced for OM1.
How can I track OM1 secondary market activity?
Caplight tracks bids, offers, and trades in OM1's shares on secondary markets.